X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2920) 2920
Publication (340) 340
Newspaper Article (161) 161
Newsletter (148) 148
Book Review (124) 124
Book / eBook (67) 67
Book Chapter (55) 55
Trade Publication Article (15) 15
Magazine Article (13) 13
Conference Proceeding (9) 9
Dissertation (6) 6
Transcript (6) 6
Report (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1938) 1938
index medicus (1802) 1802
hiv (1685) 1685
hiv infections - drug therapy (1258) 1258
human immunodeficiency virus--hiv (932) 932
pharmacology & pharmacy (900) 900
antiviral agents (871) 871
drug therapy (710) 710
hiv infection (707) 707
infectious diseases (688) 688
antiretroviral therapy (641) 641
female (622) 622
antiretroviral drugs (607) 607
male (585) 585
aids (542) 542
pharmacokinetics (522) 522
anti-hiv agents - therapeutic use (521) 521
hiv-1 - drug effects (508) 508
adult (499) 499
health aspects (473) 473
highly active antiretroviral therapy (468) 468
hiv infections - virology (396) 396
human-immunodeficiency-virus (395) 395
protease inhibitors (388) 388
middle aged (382) 382
research (365) 365
animals (359) 359
raltegravir (354) 354
drug interactions (352) 352
virology (339) 339
anti-hiv agents - administration & dosage (338) 338
immunology (338) 338
acquired immune deficiency syndrome--aids (337) 337
infection (314) 314
analysis (307) 307
anti-hiv agents - pharmacology (306) 306
hiv-1 (294) 294
drug resistance (293) 293
therapy (275) 275
microbiology (273) 273
care and treatment (272) 272
infections (254) 254
drugs (251) 251
hiv patients (250) 250
double-blind (248) 248
human immunodeficiency virus (246) 246
dosage and administration (245) 245
anti-hiv agents - pharmacokinetics (243) 243
drug therapy, combination (242) 242
anti-hiv agents - adverse effects (240) 240
clinical trials (232) 232
medicine & public health (232) 232
treatment outcome (227) 227
virus diseases (223) 223
safety (222) 222
pharmacology (220) 220
raltegravir potassium (220) 220
tenofovir (218) 218
article (215) 215
chemistry, medicinal (212) 212
drug resistance, viral (212) 212
viral load (210) 210
hiv integrase inhibitors - pharmacology (204) 204
antiretroviral agents (202) 202
immunodeficiency-virus type-1 (201) 201
integrase (201) 201
review (201) 201
in-vitro (195) 195
viruses (192) 192
ritonavir (180) 180
prevention (179) 179
hiv integrase inhibitors - pharmacokinetics (175) 175
medical research (173) 173
risk factors (172) 172
usage (172) 172
medicine (171) 171
hiv infections - complications (170) 170
proteases (168) 168
anti-hiv agents (167) 167
efavirenz (167) 167
active antiretroviral therapy (166) 166
reverse-transcriptase inhibitors (165) 165
patients (163) 163
dolutegravir (161) 161
efficacy (160) 160
hiv-1 - genetics (159) 159
hiv-infected patients (159) 159
internal medicine (159) 159
mutation (157) 157
resistance (157) 157
aids/hiv (156) 156
biochemistry & molecular biology (155) 155
emtricitabine (155) 155
research article (155) 155
young adult (153) 153
anti-retroviral agents - therapeutic use (152) 152
drug dosages (148) 148
pregnancy (148) 148
antiretroviral therapy, highly active (146) 146
hiv integrase inhibitors - therapeutic use (146) 146
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (53) 53
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Credit Valley Hospital - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3347) 3347
Spanish (25) 25
German (6) 6
Japanese (4) 4
Persian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2013, Volume 62, Issue 1, pp. 21 - 27
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 12/2006, Volume 43, Issue 5, pp. 509 - 515
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 4/2011, Volume 50, Issue 4, pp. 229 - 244
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2017, Volume 56, Issue 1, pp. 25 - 40
Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the latest class of antiretrovirals (ARVs) that have become available to treat... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | TWICE-DAILY RALTEGRAVIR | ONCE-DAILY DOLUTEGRAVIR | SERONEGATIVE SUBJECTS | TREATMENT-EXPERIENCED PATIENTS | NON-INFERIORITY TRIAL | CO-FORMULATED ELVITEGRAVIR | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | RANDOMIZED CONTROLLED-TRIAL | ANTIRETROVIRAL-NAIVE ADULTS | HIV Integrase Inhibitors - pharmacology | Coinfection | Area Under Curve | Humans | Raltegravir Potassium - therapeutic use | Half-Life | Metabolic Clearance Rate | HIV Integrase - metabolism | HIV Integrase Inhibitors - administration & dosage | Liver Failure - metabolism | Drug Interactions | Quinolones - pharmacokinetics | Quinolones - therapeutic use | Female | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Anti-Retroviral Agents - therapeutic use | Raltegravir Potassium - pharmacokinetics | Anti-Retroviral Agents - pharmacokinetics | Anti-Retroviral Agents - pharmacology | HIV Integrase Inhibitors - pharmacokinetics | Renal Insufficiency - metabolism | Pregnancy | Cytochrome P-450 CYP3A - metabolism | Anti-Retroviral Agents - administration & dosage | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | Protein Binding | HIV Infections - drug therapy | Drug Combinations | Antiviral agents | Usage | Care and treatment | Pharmacology | Research | Diagnosis | Pharmacokinetics | Comparative analysis | HIV infection | Cytochrome | Antiretroviral drugs | Enzymes | Infections | Glycoproteins | Metabolism | Patients | Studies | Proteins | Human immunodeficiency virus--HIV | Adults | Drug dosages | Volunteers
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 06/2018, Volume 58, Issue 3, pp. 1 - 15
Prevention of mother-to-child transmission of HIV and optimal maternal treatment are the most important goals of antiretroviral therapy in pregnant women with... 
PLASMA-PROTEIN-BINDING | IN-VITRO | TREATMENT-NAIVE | GESTATIONAL-AGE | RALTEGRAVIR | ANTIVIRAL ACTIVITY | PHARMACOLOGY & PHARMACY | UDP-GLUCURONOSYLTRANSFERASE 1A1 | DRUG-INTERACTION PROFILE | PHASE 2B | P-GLYCOPROTEIN | Review
Journal Article
Journal Article